【文章內(nèi)容簡介】 cate prescribers at all levels of training about medicines. 醫(yī)院藥師應抓住一切機會對各層次的處方(chǔfāng)人進行與藥物相關的教育培訓。,共識2 對處方(chǔfāng)的影響,第二十九頁，共五十九頁。,醫(yī)院藥學未來發(fā)展(fāzhǎn)共識簡介,30,27．Hospital pharmacists should have a key role in educating prescribers on the access to and evidence for optimal and appropriate use of medicines, including the required monitoring variables and prescribing adjustments. 醫(yī)院藥師在培訓(p233。ix249。n)處方人對藥品最優(yōu)、適宜的使用和循證方面應起到重要作用，包括所需的監(jiān)測參數(shù)和處方調整。,共識2 對處方(chǔfāng)的影響,第三十頁，共五十九頁。,醫(yī)院藥學未來(w232。il225。i)發(fā)展共識簡介,31,共識2 對處方(chǔfāng)的影響,28． Hospital pharmacists should be involved in all patient care areas to prospectively influence collaborative therapeutic decisionmaking. 醫(yī)院藥師應介入對患者(hu224。nzhě)服務的所有領域，以期對合作性治療決策的制定產(chǎn)生影響。,第三十一頁，共五十九頁。,醫(yī)院藥學(y224。o xu233。)未來發(fā)展共識簡介,32,共識(ɡ242。nɡ sh237。)2 對處方的影響,29． Hospital pharmacists should be an integral part of all patient rounds to assist with therapeutic decisionmaking and advise on clinical pharmacy and patient safety issues. 醫(yī)院藥師應成為每位患者的治療整體中的一個部分，協(xié)助制定治療決策，給出臨床(l237。n chu225。nɡ)藥學以及患者安全方面的建議。,第三十二頁，共五十九頁。,醫(yī)院藥學未來發(fā)展共識(ɡ242。nɡ sh237。)簡介,33,共識2 對處方(chǔfāng)的影響,30．Hospital pharmacists should provide continuity of care by transferring patient medicines information as patients move between sectors of care. 當患者轉換治療區(qū)域時，醫(yī)院藥師應移交患者用藥信息，以保障藥學(y224。o xu233。)實踐的連續(xù)性。,第三十三頁，共五十九頁。,醫(yī)院藥學(y224。o xu233。)未來發(fā)展共識簡介,34,共識(ɡ242。nɡ sh237。)2 對處方的影響,31. Postgraduate clinical courses should be developed to prepare hospital pharmacists for collaborative prescribing of medicines, including instruction in legal and professional accountability。 this role of hospital pharmacists should be promoted in the curricula of other health professionals. 應制定研究生課程(k232。ch233。ng)來培養(yǎng)醫(yī)院藥師，為協(xié)作開方做準備，包括法律和專業(yè)的責任方面的建議。醫(yī)院藥師的這種作用也應該加入到其它醫(yī)療專業(yè)課程(k232。ch233。ng)中去。,第三十四頁，共五十九頁。,醫(yī)院藥學未來(w232。il225。i)發(fā)展共識簡介,35,共識(ɡ242。nɡ sh237。)3 調配與配發(fā)（9條）,第三十五頁，共五十九頁。,醫(yī)院藥學未來(w232。il225。i)發(fā)展共識簡介,36,共識(ɡ242。nɡ sh237。)3 調配與配發(fā),32. Hospital pharmacists should ensure that proper storage conditions are provided for all medicines used in the hospital. 醫(yī)院藥師應確保為院內(nèi)的所有藥品(y224。opǐn)提供合適的貯存條件。 33. Hospital pharmacists should assume responsibility for the control of medicines stored throughout the hospital. 醫(yī)院藥師應負責院內(nèi)藥品貯存的質量控制。,第三十六頁，共五十九頁。,醫(yī)院藥學(y224。o xu233。)未來發(fā)展共識簡介,37,審方,藥師審方對保證藥物治療的安全有效(yǒuxi224。o)非常重要 在全球調研中，全球一半醫(yī)院做得不充分。,第三十七頁，共五十九頁。,醫(yī)院(yīyu224。n)藥學未來發(fā)展共識簡介,38,藥物(y224。ow249。)配置,無菌與安全的技術(j236。sh249。)對于配置藥品是需要的 在全球調研中，這一技術正在發(fā)展階段,第三十八頁，共五十九頁。,醫(yī)院藥學未來發(fā)展共識(ɡ242。nɡ sh237。)簡介,39,共識(ɡ242。nɡ sh237。)3 調配與配發(fā),34. Hospital pharmacists should ensure that compounded medicines are consistently prepared to comply with quality standards. 醫(yī)院藥師應確保提供的復配藥品始終(shǐzhōng)符合質量標準。 35. Hospital pharmacists should provide pharmacymanaged injectable admixture services using aseptic technique. 醫(yī)院藥師應采用無菌技術提供藥房配制的注射用混合液配置服務。,第三十九頁，共五十九頁。,醫(yī)院藥學未來發(fā)展共識(ɡ242。nɡ sh237。)簡介,40,共識3 調配(di224。op232。i)與配發(fā),36. Hazardous medicines including cytotoxics